Multiple Myeloma Today spoke with Raj Chakraborty, MD, assistant professor of medicine at Columbia University Irving Medical Center, Division of Hematology/Oncology, on how new research on treatments for multiple myeloma may impact the treatment landscape, and challenges and opportunities from the paradigm shift from triplet to quadruplet therapy.